Equities research analysts at Leerink Swann began coverage on shares of Livongo Health (NASDAQ:LVGO) in a research note issued on Monday, The Fly reports. The firm set an “outperform” rating and a $50.00 price target on the stock. Leerink Swann’s target price would suggest a potential upside of 42.90% from the company’s current price.

Other analysts have also issued research reports about the stock. Piper Jaffray Companies started coverage on shares of Livongo Health in a report on Monday. They issued an “overweight” rating and a $40.00 price target for the company. Chardan Capital started coverage on shares of Livongo Health in a report on Friday, August 16th. They issued a “neutral” rating and a $40.00 price target for the company. Two research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Livongo Health has a consensus rating of “Buy” and a consensus price target of $44.20.

Shares of Livongo Health stock opened at $34.99 on Monday. Livongo Health has a fifty-two week low of $31.60 and a fifty-two week high of $45.68.

In related news, major shareholder Ab (Publ) Kinnevik purchased 3,141,795 shares of the stock in a transaction that occurred on Monday, July 29th. The stock was acquired at an average price of $28.00 per share, with a total value of $87,970,260.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Hemant Taneja purchased 2,678,571 shares of the stock in a transaction that occurred on Monday, July 29th. The stock was bought at an average cost of $28.00 per share, with a total value of $74,999,988.00. The disclosure for this purchase can be found here.

About Livongo Health

Livongo Health, Inc provides an integrated suite of solutions for the healthcare industry in North America. It solutions promote health behavior change based on real-time data capture supported by intuitive devices and insights driven by data science. The company offers a platform that provides cellular-connected devices, supplies, informed coaching, data science-enabled insights, and facilitates access to medications.

Read More: What does a hold rating mean?

The Fly

Analyst Recommendations for Livongo Health (NASDAQ:LVGO)

Receive News & Ratings for Livongo Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livongo Health and related companies with MarketBeat.com's FREE daily email newsletter.